Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2019 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RAPT Therapeutics Inc | 8 | Q3 2022 | 54.2% |
NGM Biopharmaceuticals Inc | 8 | Q3 2022 | 26.3% |
Revolution Medicines Inc | 8 | Q3 2022 | 22.7% |
Nurix Therapeutics Inc | 8 | Q3 2022 | 14.9% |
Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 35.3% |
View Ponoi Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-08 |
4 | 2023-11-17 |
4 | 2023-02-01 |
4 | 2023-01-25 |
4 | 2023-01-23 |
4 | 2023-01-17 |
4 | 2023-01-12 |
4 | 2022-12-14 |
4 | 2022-11-23 |
13F-HR | 2022-11-14 |
View Ponoi Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.